2022
DOI: 10.1177/00185787221123217
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West Nigeria

Abstract: Introduction: In many low and middle-income countries (LMIC), drug promotional literature (DPL) remains one of the main sources of drug information for physicians. Studies conducted in many LMICs showed poor compliance to the WHO guidelines for ethical drug promotion especially in the area of information about excipients, adverse drug reactions, drug-drug interactions and contra-indications. These inadequacies in the information provided may mislead the prescriber with potential adverse consequences among pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 44 publications
0
4
0
Order By: Relevance
“… Provide educational support to physicians and other HCPs: Address any concerns regarding a lack of understanding or activities pertaining to antibiotics, AMR and ASPs within hospitals across Africa [ 129 , 130 ]. Outline appropriate antimicrobials to prescribe—especially pertinent where the main educational input on antibiotic prescribing in hospitals is via pharmaceutical companies and their literature [ 228 , 229 ]. Guideline and prescribing/quality indicator development: Become involved with these initiatives as well as undertake PPS studies in hospitals.…”
Section: Tablementioning
confidence: 99%
“… Provide educational support to physicians and other HCPs: Address any concerns regarding a lack of understanding or activities pertaining to antibiotics, AMR and ASPs within hospitals across Africa [ 129 , 130 ]. Outline appropriate antimicrobials to prescribe—especially pertinent where the main educational input on antibiotic prescribing in hospitals is via pharmaceutical companies and their literature [ 228 , 229 ]. Guideline and prescribing/quality indicator development: Become involved with these initiatives as well as undertake PPS studies in hospitals.…”
Section: Tablementioning
confidence: 99%
“…This is a challenge, especially in LMICs, where there are no enforced regulations influencing the objectiveness of information provided by pharmaceutical companies. This can be problematic in terms of the often limited information that is provided by companies, especially surrounding adverse reactions and safety issues, and with companies seeking to maximize the sales of their medicines [97][98][99][100]. This can be counterproductive in this situation, with the goal of governments to improve the rational use of antibiotics as part of NAPs [12,13].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, activities are ongoing within the functioning multi-sectoral coordinating committee for AMR activities [31]. As a result, they help to reduce any negative impact of promotional activities among pharmaceutical companies [75,76], which has been a concern in other African countries [157][158][159].…”
Section: Author and Yearmentioning
confidence: 99%
“…Alongside this, these key personnel should work with pharmaceutical companies to ensure that any promotional material is compliant with WHO recommendations given concerns in some African countries [157]. • Key physicians and their associations need to work closely with the Ministry of Health/health insurance groups and universities to design e-communication and other strategies to help limit patients' expectations that they will be prescribed an antibiotic for essentially self-limiting conditions such as URTIs.…”
mentioning
confidence: 99%